Achievement of complete mycological cure by topical antifungal agent NND-502 in guinea pig model of tinea pedis

Microbiology and Immunology

Volumn 47, Issue 2, 2003, Pages 143-146

  Uchida, Katsuhisa ^a   Tanaka, Takashi ^b   Yamaguchi, Hideyo ^a  

^a TEIKYO UNIVERSITY   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antifungal agent; Complete mycological cure; NND 502; Tinea pedis

Indexed keywords

ACETONITRILE DERIVATIVE; ANTIFUNGAL AGENT; UNCLASSIFIED DRUG; [4 (2,4 DICHLOROPHENYL) 1,3 DITHIOLAN 2 YLIDENE] 1 IMIDAZOLYLACETONITRILE; [4 (2,4 DICHLOROPHENYL) 1,3 DITHIOLAN 2 YLIDENE](1 IMIDAZOLYL)ACETONITRILE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CREAM; DERMATOPHYTE; DRUG EFFICACY; FEMALE; FUNGUS CULTURE; GUINEA PIG; NONHUMAN; TIME SERIES ANALYSIS; TINEA PEDIS; TREATMENT OUTCOME; TRICHOPHYTON MENTAGROPHYTES;

ANIMALIA; ARTHRODERMA BENHAMIAE; ARTHRODERMATACEAE; CAVIA; CAVIA PORCELLUS; FUNGI; SUS SCROFA; TINEA; TRICHOPHYTON;

EID: 0345505652     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2003.tb02797.x     Document Type: Article

References (21)

1. Arika, T., Yokoo, M., Hase, T., Meada, T., Amemia, K., and Yamaguchi, H. 1990. Effects of butenafine hydrochloride, a new benzylamine derivative, on experimental dermatophytosis in guinea pigs. Antimicrob. Agents Chemother. 34: 2250-2253.
2. Arika, T., Yokoo, M., and Yamaguchi, H. 1992. Topical treatment with butenafine significantly lowers relapse rate in an interdigital tinea pedis model in guinea pigs. Antimicrob. Agents Chemother. 36: 2523-2525.
3. Fujita, S., and Matsuyama, T. 1987. Experimental tinea pedis induced by non-abrasive inoculation of Trichophyton mentagrophytes arthrospores on the plantar part of a guinea pig foot, J. Med. Vet. Mycol. 25: 202-213.
4. Fujita, S., and Matsuyama, T. 1988. Experimental tinea pedis - animal model quite similar to human tinea pedis, p. 51-54. In Miyaji, M. et al. (eds), Proceedings of IInd International Symposium of Research Center for Pathogenic Fungi & Microbial Toxicosis, Current Problem of Fungal Infection, Chiba University, Chiba.
5. Fujita, S. 1992. Conditions required for successful experimental dermatophytosis and its histopathogenesis. Jpn. J. Med. Mycol. 33: 115-125.
6. Itoyama, T., Uchida, K., and Yamaguchi, H. 1997. Therapeutic effects of omoconazole nitrate on guinea-pigs experimentally infected with Trichophyton mentagrophytes. J. Antimicrob. Chemother. 39: 825-827.
7. Kagawa, S., Takahashi, S., Takahashi, H., Nishikawa, T., and Watanabe, S., SS717 Clinical Research Group. 1991. Clinical evaluation of SS717 cream in the treatment of dermatomycosis - a randomized comparative study with bifonazole cream as control Clin. Rep. 25: 415-446.
8. Niwano, Y., Kuzuhara, N., Gotoh, Y., Miyazaki, T., and Yamaguchi, H. 1997. Therapeutic efficacy of NND-502, a novel topical antifungal agent, against experimental cutaneous mycoses, 13th Congress of the International Society for Human and Animal Mycology, Parma, Italy, June 8-13, Abstract, p. 220.
9. Niwano, Y., Kuzuhara, N., Kodama, H., Yoshida, M., Miyazaki, T., and Yamaguchi, H. 1998. In vitro and in vivo antidermatophyte activities of NND-502, a novel optically active imidazole antimycotic agent. Antimicrob. Agents Chemother. 42: 967-970.
10. Ohmi, T., Konaka, S., Uchida, M., and Yamaguchi, H. 1991. Antifungal activity of the new agent lanoconazole in two tinea models. Arzneim.-Forsch./Drug Res. 41: 847-851.
11. Oka, H., Niwano, Y., Tanaka, T., Uchida, M., and Yamaguchi, H. 1992. Therapeutic efficacy of lanoconazole in formulations of clinical use on experimental dermatophytosis in guinea pigs. Arzneim.-Forsch./Drug Res. 42: 345-349.
12. Padhye, A.A., and Weitzman, I. 1998. Medical mycology, p. 215-236. In Ajello, L., and Hay, R,J. (eds), Topley & Wilson's microbiology and microbial infection. The Hodder Headline Group, London.
13. Report of the Standardization Committee of the Japanese Society of Medical Mycology 1995-1997. 1999. Jpn. J. Med. Mycol. 40: 239-257.
14. Takahashi, H. 1983. New method for the in vivo animal evaluation of topical fungicides. Jpn. J. Med. Mycol. 24: 230-233.
15. Takahashi, H., The Second Study Group of Liranaftate Cream. 1993. Clinical evaluation of 2% liranaftate cream in treatment of dermatophytosis: open trial (Phase III study) of 2% liranaftate cream. Jpn. Pharmacol. Ther. 21: 509-522.
16. Uchida, K., and Yamaguchi, H. 1991. Therapeutic efficacy of terbinafine cream, a new allylamine antimycotic, in guinea pig dermatophytosis model. Jpn. J. Med. Mycol. 32: 333-342.
17. Uchida, K., Matsuzaka, A., and Yamaguchi, H. 1991. Therapeutic effect of amorolfine on experimental dermatophytosis. Jpn. J. Antibiot. 44: 1020-1031.
18. Uchida, K., Kudho, M., and Yamaguchi, H. 1994. A study on effectiveness of treatment and prevention of relapse using topical administration of terbinafine in a guinea pig model for tinea pedis. Jpn. J. Antibiot. 47: 1407-1412.
19. Uchida, K., and Yamaguchi, H. 1999. Therapeutic efficacy of a topical antifungal solution preparation formulated with pyrrolnitrin and clotrimazole in combination in guinea pig model of tinea pedis. Jpn. J. Antibiot. 52: 68-74.
20. Urabe, H., Matsumoto, T., and Hombo, S. (eds), 1993. Textbook of medical mycology, Kanehara & Co., Ltd., Tokyo.
21. Yamaguchi, H., Uchida, K., Tanaka, T., and Yamaguchi, T. 2001. Therapeutic efficacy of a topical tolnaftate preparation in guinea pig model of tinea pedis. Jpn. J. Antibiot. 54: 323-330.